Disparities in Reported Testing for 1p/19q Codeletion in Oligodendroglioma and Oligoastrocytoma Patients: An Analysis of the National Cancer Database

PURPOSE: A chromosomal 1p/19q codeletion was included as a required diagnostic component of oligodendrogliomas in the 2016 World Health Organization (WHO) classification of central nervous system tumors. We sought to evaluate disparities in reported testing for 1p/19q codeletion among oligodendrogli...

Descripción completa

Detalles Bibliográficos
Autores principales: Zreik, Jad, Kerezoudis, Panagiotis, Alvi, Mohammed Ali, Yolcu, Yagiz U., Kizilbash, Sani H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630738/
https://www.ncbi.nlm.nih.gov/pubmed/34858822
http://dx.doi.org/10.3389/fonc.2021.746844

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630738/
https://www.ncbi.nlm.nih.gov/pubmed/34858822
http://dx.doi.org/10.3389/fonc.2021.746844

Ejemplares similares